ICD-10-CM Billable Code

Q99.81

Usher syndrome

Clinical Classification Guidelines

Use Additional Code

  • code to identify any auditory and visual manifestations

Medical Intelligence & Overview

Usher syndrome is a rare genetic disorder characterized by a combination of hearing loss and vision loss. It is recognized as a leading cause of deaf-blindness, affecting both auditory and visual functions. People with this syndrome often experience progressive symptoms that worsen over time, significantly impacting their communication, mobility, and overall quality of life. Early diagnosis and management are essential to maximize independence and facilitate access to supportive services.

Causes & Symptoms

Clinical Causes: Genetic mutations are the primary cause of Usher syndrome, passed down from parents to children. It involves inherited gene defects that affect the inner ear's hair cells responsible for hearing and the retina in the eyes responsible for vision. There are different types of Usher syndrome (Type 1, Type 2, and Type 3), each associated with different genes and severity of symptoms. The disorder is inherited in an autosomal recessive pattern, meaning a person needs to inherit two copies of the mutated gene to be affected. Family history of the disorder increases the risk of inheritance.

Key Symptoms: Hearing loss at birth or in early childhood, which may be profound or partial. Progressive loss of vision, typically due to retinitis pigmentosa, leading to night blindness and loss of peripheral vision. Difficulty seeing in low light conditions or at night. Delayed or impaired speech development in children with congenital hearing loss. Balance problems in some cases, especially in the early stages, due to inner ear issues. Tinnitus, or ringing in the ears, may also be experienced by some individuals.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of Usher syndrome involves a combination of clinical evaluations and genetic testing. - **Hearing assessments** such as audiograms to determine the degree of hearing loss. - **Ophthalmologic exams** to evaluate retinal health and detect signs of retinitis pigmentosa. - **Genetic testing** to identify mutations in genes associated with Usher syndrome. - **Electroretinogram (ERG)** to assess retinal function. - **Family history analysis** to understand inheritance patterns. Early detection is crucial for planning management strategies and adjusting educational or support services.

Treatment Protocols: While there is currently no cure for Usher syndrome, various treatments and interventions can improve quality of life. - **Hearing loss management:** Use of hearing aids or cochlear implants, especially in cases of severe or profound loss. - **Visual assistance:** Low vision aids, orientation and mobility training, and adaptive devices to help navigate environments. - **Regular medical evaluations:** Ongoing monitoring of hearing and vision to adapt interventions as needed. - **Communication support:** Speech therapy and sign language education for those with significant hearing impairment. - **Genetic counseling:** Providing information to affected individuals and families about inheritance patterns and future risks. - **Research and clinical trials:** Participation in studies exploring potential treatments, including gene therapy, is encouraged as new options develop.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q99.81 a billable ICD-10 code?
Yes, Q99.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q99.81?
Clinical documentation must specify the nature of Usher syndrome and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

usher syndrome